Join Clinical Trials for Pneumonia
The lung inflammation that characterizes pneumonia is typically caused by a bacterial, viral, or fungal infection.
Furthermore, specific groups of individuals are more likely to develop pneumonia than others, including individuals over age 65 and those under the age of 2, as well as those who have pre-existing health problems, including heart failure, diabetes, and COPD.
In light of these known facts about pneumonia, research seeks to improve methods of preventing, diagnosing, and treating pneumonia.
What Will Pneumonia Clinical Trials Be Like?
When participating in a clinical trial for pneumonia, a few common tests and procedures may be involved; however, the ultimate design of the particular study will determine which specific procedures you will undergo.
On a basic level, you may be asked to provide a detailed history describing your symptoms, their duration, severity, and current or recent exposures (i.e., to people, animals, and travel). Your lungs will likely be examined by the study doctor through the use of a stethoscope.
In addition, you may have a chest x-ray to better visualize the infection in your lungs, or to monitor the progress of a specific treatment you are receiving for your pneumonia. Blood tests might also be involved to monitor signs of infection or your response to medications.
You may also be asked to provide a sputum/spit sample, undergo a CT scan (which is an x-ray like procedure that provides detailed images of areas inside your body), or undergo a procedure known as thoracentisis (the removal of fluid from the space between the outside lining of your lungs and the chest wall).
Your pulse and the amount of oxygen in your blood may also be measured, and you may be asked to undergo a bronchoscopy (a procedure in which your doctor inserts a flexible tube with a light on the end through your nose or mouth and into your airways).
Typical Pneumonia Clinical Trial Protocol:
Examples of pneumonia-related clinical trials might include the following:
- A study to determine if proactive treatment with antibiotics or antiviral medications in hospitalized patients with heart disease helps to prevent the development of pneumonia.
- A study to determine the risk of pneumonia among individuals who smoke.
- A study to determine the effectiveness of a newly-developed antibacterial or antiviral medication in treating pneumonia.
- A study to determine the accuracy of a newly-developed diagnostic tool or imaging procedure to correctly diagnose the presence of pneumonia.
- A study designed to determine the risk of developing pneumonia among individuals who received different types of breathing tubes during surgical procedures.
Suggested Search Terms:
“pneumonia children,” “pneumonia treatment,” “pneumonia bacteria,” “pneumonia virus,” “pneumonia COPD,” and “pneumonia surgery.”
Current Search Term: